Neumora Therapeutics, Inc. (NMRA)
NASDAQ: NMRA · Real-Time Price · USD
1.340
-0.150 (-10.07%)
At close: Mar 10, 2025, 4:00 PM
1.391
+0.051 (3.81%)
Pre-market: Mar 11, 2025, 5:13 AM EST

Neumora Therapeutics Stock Forecast

NMRA's stock price has decreased by -92.56% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 7 analysts with 12-month price forecasts for Neumora Therapeutics stock have an average target of 10.14, with a low estimate of 2.00 and a high estimate of 20. The average target predicts an increase of 656.72% from the current stock price of 1.34.

Analyst Consensus: Buy
Target Low Average Median High
Price $2.00 $10.14 $7.00 $20
Change +49.25% +656.72% +422.39% +1392.5%

Analyst Ratings

The average analyst rating for Neumora Therapeutics stock from 8 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Oct '24Nov '24Dec '24Jan '25Feb '25Mar '25
Strong Buy 222333
Buy 322221
Hold 011114
Sell 000000
Strong Sell 000000
Total 555668

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Guggenheim
Guggenheim
Hold
Downgrades
n/a
Hold Downgrades n/a n/a Mar 10, 2025
Stifel
Stifel
Hold
Downgrades
$6$2
Hold Downgrades $6$2 +49.25% Mar 7, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$18
Strong Buy Reiterates $18 +1,243.28% Mar 7, 2025
RBC Capital
RBC Capital
Hold
Reiterates
$4
Hold Reiterates $4 +198.51% Mar 4, 2025
Needham
Needham
Strong Buy
Reiterates
$5
Strong Buy Reiterates $5 +273.13% Mar 4, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
22.50M
EPS This Year
-1.65
from -1.53
EPS Next Year
-1.62
from -1.65
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027
Revenue
------22.50M176.14M
Revenue Growth
-------682.81%
EPS
-7.64-10.84-4.81-3.63-1.53-1.65-1.62-1.12
EPS Growth
--------
Forward PE
--------
No. Analysts -----1196
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20252026202720282029
High n/a 82.3M 247.0M
Avg n/a 22.5M 176.1M
Low n/a n/a 21.9M

Revenue Growth

Revenue Growth 20252026202720282029
High - -
997.5%
Avg - -
682.8%
Low - -
-2.9%

EPS Forecast

EPS 20252026202720282029
High -1.17 -0.68 -0.67
Avg -1.65 -1.62 -1.12
Low -1.90 -2.06 -1.34

EPS Growth

EPS Growth 20252026202720282029
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.